GME
77
-3
ITW
21
-7
CRM
25
-9
L
39
-7
HBI
43
-6
WFC
57
-6
SBUX
27
-5
DAL
32
-11
ECL
29
-6
WBA
27
-4
DTE
25
-6
AA
19
-2
BF.B
43
-4
NEM
50
4
NI
51
-4
PRGO
24
-8
HOG
31
-9
PEG
44
-7
NVDA
42
-10
AMAT
33
-10
GME
77
-3
ITW
21
-7
CRM
25
-9
L
39
-7
HBI
43
-6
WFC
57
-6
SBUX
27
-5
DAL
32
-11
ECL
29
-6
WBA
27
-4
DTE
25
-6
AA
19
-2
BF.B
43
-4
NEM
50
4
NI
51
-4
PRGO
24
-8
HOG
31
-9
PEG
44
-7
NVDA
42
-10
AMAT
33
-10
Financhill
Back

Alnylam Pharmaceuticals Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
22

ALNY
Alnylam Pharmaceuticals

Last Price:
$237.59
Seasonality Move:
8.79%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
$51.00
Seasonality Move:
12.51%
Sell
22
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $226.28. The Score for ALNY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $50.31. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $226.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $50.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.58 Sell
Relative Strength Index (14 RSI): 39.48 Sell
Chaikin Money Flow: 198834 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (236.3 - 271.12) Sell
Bollinger Bands (100): (238.38 - 267.68) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.43 Sell
Relative Strength Index (14 RSI): 25.41 Sell
Chaikin Money Flow: -2337291 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.24 - 93.24) Sell
Bollinger Bands (100): (85.21 - 128.11) Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 243.41 Sell
20-day SMA: 256.36 Sell
50-day SMA: 257.24 Sell
200-day SMA: 258.01 Sell
8-day EMA: 241.53 Sell
20-day EMA: 250.36 Sell
50-day EMA: 253.97 Sell
200-day EMA: 244.7 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.64 Sell
20-day SMA: 68.68 Sell
50-day SMA: 92.51 Sell
200-day SMA: 121.01 Sell
8-day EMA: 56.28 Sell
20-day EMA: 67.87 Sell
50-day EMA: 86.24 Sell
200-day EMA: 111.03 Sell

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $1.34 per share, an increase this year of $1.07 per share, and an increase next year of $2.82 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.35 per share, a decrease next quarter of $0.47 per share, an increase this year of $4.58 per share, and an increase next year of $5.49 per share.

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):